tbuckley/cabot-search huggingface dataset:
Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL
Authors: Darko Antic, Natasa Milic, Thomas Chatzikonstantinou, Lydia Scarfò, Vladimir Otasevic, Nina Rajovic, David Allsup, Alejandro Alonso Cabrero, Martin Andres, Monica Baile Gonzales, Antonella Capasso, Rosa Collado, Raul Cordoba, Carolina Cuéllar-García, Juan Gonzalo Correa, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Maria Dimou, Michael Doubek, Maria Efstathopoulou, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Alberto Lopez-Garcia, Jose A. Garcia-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Maria Gomes da Silva, Odit Gutwein, Yervand Hakobyan, Yair Herishanu, José Ángel Hernández-Rivas, Tobias Herold, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B. Kalashnikova, Elżbieta Kalicińska, Arnon P. Kater, Sabina Kersting, Maya Koren-Michowitz, Jorge Labrador Gomez, Deepesh Lad, Luca Laurenti, Alberto Fresa, Mark-David Levin, Carlota Mayor Bastida, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Biljana Mihaljevic, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Raquel Nunes, Jacopo Olivieri, Miguel Arturo Pavlovsky, Inga S. Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Gianluigi Reda, Gian Matteo Rigolin, Amit Shrestha, Martin Šimkovič, Svetlana Smirnova, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Doreen Te Raa, Kristina Tomic, Sanne Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Marzia Varettoni, Andrea Visentin, Candida Vitale, Vojin Vukovic, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yanez San Segundo, Mohamed A Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Robin Foà, Antonio Cuneo, Marc Carrier, Paolo Ghia, Kostas Stamatopoulos
Journal: Blood (2022)
Updated Outcomes in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Using Tyrosine Kinase Inhibitors Combined with the Modified University of Southern California (USC ALL) Regimen without Peg-Asparaginase in the Era of Novel Agents
Authors: Vincent Louie Louie Mendiola, Catherine Ly, Jennifer Wang, Thuy Bui, Jack Rodman, Amir Ali, Karrune Woan, Eric Tam, Maria E. Vergara-Lluri, Preet M. Chaudhary, Dan Douer, Abdullah Ladha, George Yaghmour
Journal: Blood (2022)
Preliminary Safety and Efficacy from Apex, a Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent <i>KIT</i> D816V Tyrosine Kinase Inhibitor, in Adults with Advanced Systemic Mastocytosis (AdvSM)
Authors: Daniel J. DeAngelo, Vinod A. Pullarkat, Miguel Piris-Villaespesa, Tracy I. George, Jay L. Patel, Celalettin Ustun, Prithviraj Bose, Mark L Heaney, Jessica Sachs, Lei Sun, Amanda Pilla, Benjamin Exter, Hina A. Jolin, Tsewang Tashi
Journal: Blood (2022)
Increased Potency and Uniformity of Fetal Hemoglobin Induction from Base Editing Compared to Cas9 Nuclease
Authors: Thiyagaraj Mayuranathan, Gregory A. Newby, Ruopeng Feng, Yu Yao, Kalin Mayberry, Guolian Kang, Cicera Lazzarotto, Yichao Li, Rachel Levine, Erin Dempsey, Shaina N. Porter, Phillip A Doerfler, Jingjing Zhang, Yoonjeong Jang, Senthil Bhoopalan, Nikitha Nimmagadda, Akshay Sharma, John Tisdale, Shondra Miller, Yong Cheng, Shengdar Tsai, Mitchell J. Weiss, David R. Liu, Jonathan S Yen
Journal: Blood (2022)
An Ex Vivo Monocyte Stimulation Test Predicts Severity of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia (CLL)
Authors: Gordon Ruan, Xiaosheng Wu, Kimberly Gwin, Michelle K. Manske, Jithma P. Abeykoon, Taylor L. Witter, Matthew J. Schellenberg, Kari G Rabe, Sara J. Achenbach, Neil E. Kay, Sameer A. Parikh, Thomas E. Witzig
Journal: Blood (2022)
Long-Term Persistence of Mixed Full Donor Chimerism after Double Cord Blood Transplantation. Example of Tolerance in Allogeneic Hematopoietic Cell Transplantation Setting
Authors: Carole Saison, Virginie Mathias, Marie Balsat, Fiorenza Barraco, Sophie Ducastelle, Catherine Giannoli, Hélène Labussière-Wallet, Dan Adrian Luscalov, Philippe Moskovtchenko, Valerie Dubois, Mauricette Michallet
Journal: Blood (2022)
Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in Therapy-Related Myelodysplastic Syndromes
Authors: Luis E. Aguirre, Najla Al Ali, Somedeb Ball, Avani M Singh, Akriti G Jain, Onyee Chan, Zaker I. Schwabkey, Sara M Tinsley-Vance, Andrew Kuykendall, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David A. Sallman, Rami S. Komrokji
Journal: Blood (2022)
A Role of Immunothrombosis in Acquired Antibody-Mediated Thrombophilia's: Classical Complement and Neutrophil Activation in APS and HIT
Authors: Annina Capraru, Tiphaine Ruggeri, Noelia Schärz, Laura Delvasto-Nunez, Justine Brodard, Gerard van Mierlo, Johanna A. Kremer Hovinga Strebel, Anne Angelillo-Scherrer, Ilse Jongerius, Sacha Sergio Zeerleder
Journal: Blood (2022)
Exposure-Response Analysis Supports a Lower Dose of Venetoclax in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma Patients When Combined with Daratumumab and Dexamethasone
Authors: Mohamed A Badawi, Benjamin Engelhardt, Jesus Badillo, Ahmed Abbas Suleiman, Leanne Lash Fleming, Yan Luo, Jonathan L. Kaufman, Nizar Jacques Bahlis, Rajeev Menon, Ahmed Hamed Salem
Journal: Blood (2022)
Canonical Thrombopoietin Receptor Mutants in Myeloproliferative Neoplasms Rely Differently on the Extracellular Domain of the Receptor but Share Similar Mechanisms of Inactivation: An Open Field for the Development of New Therapies
Authors: Gabriel Levy, Nicolas Papadopoulos, Christian Pecquet, Jean-Philippe Defour, Emilie Leroy, Nabih Maslah, Bruno Cassinat, Steven Smith, Stefan N Constantinescu
Journal: Blood (2022)
Combined Inhibition of CDK2 and BCL2 Overrides Resistance to Targeting BTK and CDK4/6 in Mantle Cell Lymphoma Therapy
Authors: Haya Y. Al-Ansari, Saira Bashir, Adrienne Cui, Xiangao Huang, Yang Hu, Peter Martin, Olivier Elemento, Maurizio Di Liberto, Selina Chen-Kiang
Journal: Blood (2022)
ASC4START: A Phase IIIb, Open-Label, Randomized Study of Tolerability and Efficacy of Asciminib Versus Nilotinib in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in Chronic Phase
Authors: Andreas Hochhaus, Susanne Saussele, Francois-Xavier Mahon, Virginia Pilipovic, Yifan Zhang, Peter Schuld, Tim H. Brümmendorf
Journal: Blood (2022)
Impact of Cytomegalovirus (CMV) Sero-Conversion Pre Allogeneic Stem Cell Transplant on Post-Transplant Outcomes
Authors: Ayman Sayyed, Leeann Wilson, Vered Stavi, Shiyi Chen, Jonas Mattsson, Jeffrey H. Lipton, Dennis D.H. Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun D. Law, Armin Gerbitz, Ivan Pasic, Igor Novitzky-Basso, Fotios V. Michelis
Journal: Blood (2022)
Treatment- Free Remission in Chronic Myeloid Leukemia -Experience of a Single Brazilian Private Institution Using Imatinib Copies
Authors: Renato Torrescasana Centrone, Marcelo Bellesso, Rodrigo Santucci Silva, Daniela Ferreira Dias, Israel Bendit, Jhony ARANHA Lima Alves, Felipe Ribeiro Bruniera, Ariel Testasicca Trunkel, Adelson Alves da Silva
Journal: Blood (2022)
Interim Results from Clevo: A Non-Interventional Cohort Study Investigating the Clonal Evolution of <i>FMS-like Tyrosine Kinase</i> <i>3</i> (<i>FLT3</i>) Mutations during Disease Progression in Patients with Acute Myeloid Leukemia
Authors: Cristina Papayannidis, Blanca Boluda, Jonathan Canaani, Pascal Turlure, Ann De Becker, Anand Tandra, Dina Elsouda, Arnaud Houweling, Anil Upadhyay, Isabelle Wouters, Paresh Vyas
Journal: Blood (2022)
Cohesin Dependency in <i>Npm1</i>c/+ and <i>Flt3</i>-ITD Mutant Hematopoietic Stem and Progenitor Cells
Authors: Jane J Xu, Besmira Alija, Stephanie Braunstein, John Pantazi, Varun S Sudunagunta, Robert L. Bowman, Aaron D Viny
Journal: Blood (2022)
A Phase1/1b Dose Escalation/Dose Expansion Study of Prgn-3007 Ultracar-T Cells in Patients with Advanced Hematologic and Solid Tumor Malignancies
Authors: Javier Pinilla Ibarz, Amy Lankford, Helen Sabzevari, Bijal D. Shah, Hatem Soliman, Julio C. Chavez, Rutul R Shah
Journal: Blood (2022)
Measurable Residual Disease Conversion Rate with Consolidation Chemotherapy in Acute Myeloid Leukemia
Authors: Daria Gaut, Caspian Oliai, Jonathan Boiarsky, Shiliang Zhang, Tali Azenkot, Vanessa E. Kennedy, Vishesh Khanna, Karla Olmedo Gutierrez, Navika D. Shukla, Benjamin Moskoff, Anand Ashwin Patel, Deepa Jeyakumar, Gabriel N. Mannis, Aaron C. Logan, Brian A. Jonas, Gary J. Schiller
Journal: Blood (2022)
1-Year Results from a Phase 2 Study to Determine Safety and Tolerability of Treating Patients with Light-Chain (AL) Amyloidosis with Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia
Authors: Jason Valent, Michaela Liedtke, Jeffrey A. Zonder, Mark Tulchinskiy, Chandrasekhar Udata, Girly Ramirez, Kate Szymaniak, Julia Catini, Candida Cristina Quarta
Journal: Blood (2022)
RGI-2001 Infusion for Prevention of Acute Gvhd after Allogeneic Hematopoietic Cell Transplantation
Authors: Yi-Bin Chen, Ayman Saad, Shatha Y. Farhan, Lazaros J. Lekakis, Gary J. Schiller, Jean A. Yared, Amer Assal, Dana D Lee, Hayley Lane, Ted A. Gooley, Zachariah Defilipp
Journal: Blood (2022)
Distinguishing Early Infections from CRS with Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL
Authors: Kai Rejeski, Viktoria Blumenberg, Simon KG Forsberg, Agnese Petrera, Niklas Mueller, Friederike Hildebrandt, Lisa Frölich, Philipp Karschnia, Christian Schmidt, Martin Dreyling, Michael von Bergwelt, Marion Subklewe, Veit L Buecklein
Journal: Blood (2022)
Bone Marrow Plasma Proteome Analysis By Differential Ultracentrifugation and Tandem Mass Spectrometry Allow for Characterization of Leukemia-Derived Extracellular Vesicles in Patients with Acute Lymphoblastic Leukemia
Authors: Ole Østergaard, Hanne Vibeke Marquart, Maria Thastrup, Christian Mirian, Bodil Als-Nielsen, Kjeld Schmiegelow, Jesper V Olsen, Signe Modvig
Journal: Blood (2022)
Single Centre, Retrospective Analysis of Treatment Outcomes and Prognostic Factors in Blastic Phase Chronic Myeloid Leukemia (CML-BP) Following Systemic Therapy
Authors: Kenny Tang, Dawn Maze, Karen Yee, Hassan Sibai, Marta B. Davidson, Steven M. Chan, Aaron D. Schimmer, Andre C. Schuh, Aniket Bankar, Guillaume Richard-Carpentier, Anne Tierens, Mark D. Minden, Vikas Gupta, Jeffrey H. Lipton, Dennis Kim
Journal: Blood (2022)
Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma
Authors: Hiroyuki Takamatsu, Daisuke Ikeda, Toshiki Terao, Takeshi Yamashita, Ryota Urushihara, Yuzuki Hatano, Nana Hirose, Natsu Yamada, Ryoichi Murata, Toshihiro Miyamoto, Kosei Matsue
Journal: Blood (2022)
Two Is Better Than One: Fetal Hemoglobin Reactivation and Alpha-Globin Downregulation to Correct the β-Hemoglobinopathy Phenotype through Base Editing
Authors: Panagiotis Antoniou, Mathieu von Joest, Letizia Fontana, Giulia Hardouin, Pierre Martinucci, Marina Cavazzana, Annarita Miccio
Journal: Blood (2022)
A Comparison of Outcomes in Patients with Secondary Acute Promyelocytic Leukemia (APL) and <i>De Novo</i> APL - a Case-Match Retrospective Analysis of Polish Adult Leukemia Group (PALG)
Authors: Agnieszka Pluta, Marta Anna Sobas, Damian Mikulski, Kinga Krawiec, Magdalena Czemerska, Bozena Katarzyna Budziszewska, Tomasz Wróbel, Marzena Watek, Ewa Lech-Marańda, Tomasz Gromek, Dorota Hawrylecka, Marek Hus, Ewa Zarzycka, Jan Zaucha, Anna Armatys, Grzegorz Helbig, Jolanta Oleksiuk, Jaroslaw Piszcz, Andrzej Szczepaniak, Lidia Gil, Rafal Becht, Wojciech Fendler, Sebastian Giebel, Agnieszka Wierzbowska
Journal: Blood (2022)
Clinical Outcomes and Salvage Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Progression on BCMA-Targeted CAR-T Therapy
Authors: Kevin R Reyes, Yen-Chun Liu, Chiung-Yu Huang, Rahul Banerjee, Thomas Martin, Nina Shah, Sandy W. Wong, Jeffrey L. Wolf, Shagun Arora, Alfred Chung
Journal: Blood (2022)
Trial in Progress: A Phase II Window of Opportunity Study of the BCMAxCD3 Bispecific Antibody REGN5458 in Previously Untreated Patients with Symptomatic Multiple Myeloma
Authors: Christopher J. Ferreri, Steven E. Quatela, Sean Aina, Pourab Roy, Anita Boyapati, Karen Rodriguez Lorenc, Glenn S. Kroog, Robert Z. Orlowski
Journal: Blood (2022)
Mitotic Perturbation Is a Key Mechanism of Action of Decitabine in Myeloid Tumor Treatment
Authors: Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, Shuhei Asada, Keita Yamamoto, Naru Sato, Yutaka Enomoto, Yosuke Tanaka, Keiko Katoh, Kaori Saitoh, Takamasa Ishikawa, Hitoshi Sato, Tomoyoshi Soga, Yasuhito Nannya, Makoto Nakanishi, Daiju Kitagawa, Toshio Kitamura, Susumu Goyama
Journal: Blood (2022)
Functional Human iPSC-Derived Thymic Epithelial Progenitor Cells Reconstitute T Cell Development and Function in an <i>In Vivo</i> Model of Thymic Aplasia
Authors: Priscila Ferreira Slepicka, Phd, Kelsea M Hubka, Hanh Dan Nguyen, Abdulvasey Mohammed, Jing Wang, Casey Gifford, Vittorio Sebastiano, Katja G. Weinacht
Journal: Blood (2022)
Lenalidomide-Rituximab or Lenalidomide-Rituximab-Bendamustine in Patients with Relapsed/Refractory Follicular Lymphoma: Priimary Analysis of the Randomized Phase II HOVON110/Rebel Trial
Authors: Marie José Kersten, Martin Dreyling, Kim M. Linton, Dana Chitu, Sanne Tonino, Marcel Kap, Roberto D Liu, Martine E.D. Chamuleau, Hein P.J. Visser, Eva De Jongh, Erik WAF Marijt, Maria B.L. Leijs, Yavuz M. Bilgin, Jan Dürig, Pamela McKay, Tjeerd J.F. Snijders, Andrew Pettitt, Monique C. Minnema, Gabriele Prange-Krex, Maria Cuijpers, Lara H. Böhmer, Lidwine W. Tick, Axel Florschütz, Matthijs Silbermann, Rob Fijnheer, Aart Beeker, Nelleke Tolboom, Cristina Mitea, Anne IJ Arens, Gerben JC Zwezerijnen, Wolfram Klapper, Sarah E. Coupland, Daphne de Jong, Jeanette K. Doorduijn, Josée M. Zijlstra
Journal: Blood (2022)
Pre-Clinical Development of a First in Class Half-Life Extended T Cell Engager Targeting ROR-1
Authors: David Granger, Patricia Henne, Annalisa Baccaro, Dinusha Fernando, Jasmine Gore, Ephraim Gbajumo, Vincent Muczynski, Mittal Shah, Kieran O'Donovan, Kerry Chester, Amit C. Nathwani
Journal: Blood (2022)
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic Graft vs. Host Disease: A Report of Two Phase I/II Trials
Authors: Eduardo Rodriguez Arbolí, Catherine J. Lee, Teresa Caballero, Clara Garcia-Calderon, Carmen Martinez, Maria Aranzazu Bermudez, Lucía López Corral, Ana Triguero, Lynn E. Onstad, Stefanie Sarantopoulos, Stephanie J. Lee, Jose A. Perez-Simon
Journal: Blood (2022)
Identification of Global miRNA Targetomes within Human Hematopoietic Progenitors and Acute Myeloid Leukemia Uncovers Unique Molecular Networks Centered on Mitochondria Function in Leukemic Stem Cells
Authors: Gabriela Krivdova, Brian Yee, Stefan Aigner, Martino Gabra, Alexander Shishkin, Long Nguyen, Jessica L McLeod, Leah Carley, Leonardo Salmena, Lorien Shakib, Mark D. Minden, Eric L Van Nostrand, Gene W. Yeo, Eric R. Lechman, John E. Dick
Journal: Blood (2022)
CHD4 Loss Alters Chromatin Accessibility Giving Rise to Sensitivity to DNA Damage Repair Compounds in Acute Myeloid Leukaemia
Authors: Deirdra Venney, Graeme M Greenfield, Lauren V Cairns, Paul Strain, Áine E McGill, Jonathan J Morgan, Róisín M McAvera, Fatemeh Mirzadeh, Yaser Atlasi, Adone Mohd-Sarip, Ken I Mills
Journal: Blood (2022)
Identifying Multiple Myeloma Patients Using Automated Data Capture from Electronic Medical Records
Authors: Aaron S Rosenberg, Albert William Riedl, Michelle A. Quan, Kwan-Keat Ang, Joseph M Tuscano, Naseem S Esteghamat, Brian A. Jonas, John Graff, Matthew Renquist, Joseph Cawood, Jeanna L Welborn, Rasmus T Hoeg, Paul R. Kaesberg, Kent Anderson, Jason Y Adams, Theresa H.M. Keegan
Journal: Blood (2022)
Pre-Clinical Efficacy of AB-101, an Allogeneic Cord-Blood Derived Natural Killer (NK) Cell Therapeutic Candidate, in Combination with Anti-CD38 Antibodies in Models of Multiple Myeloma
Authors: Gina Chu, Kun-Yu Teng, Lisa Guerrettaz, Rodrigo Fernades Da Silva, Salvatore Rotondo, Claudia Palomino La Torre, Amanda Conerty, Peter Flynn, Anita Seto, Heather Raymon, Srinivas Somanchi
Journal: Blood (2022)
Tissue Factor Positive Extracellular Vesicles and Risk of Thromboembolism in Diffuse Large B-Cell Lymphoma: A Prospective Exploratory Study
Authors: Vladimir Otasevic, Charlotte Gran, Natasa Milic, Vojin Vukovic, Biljana Mihaljevic, Jawed Fareed, Nida Mahmoud Hourani Soutari, Jovan Antovic, Darko Antic
Journal: Blood (2022)
Alberta Cellular and Immunotherapy (ACIT) 001, Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)
Authors: Michael P. Chu, Zack M. Breckenridge, Andrew Daly, Mona Shafey, Victor A. Lewis, Sunil J. Desai, Peng Wang, Joseph Brandwein, Peter Duggan, Beverly Wilson, Bindu Thapa, Carina Debes-Marun, Irwindeep Sandhu
Journal: Blood (2022)
Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults with Severe Hemophilia Α
Authors: Adam Giermasz, Nathan Visweshwar, Thomas J. Harrington, Andrew D Leavitt, Barbara Konkle, Jeremy Rupon, Gregory Di Russo, Li-Jung Tseng, Maria de los Angeles Resa, Florence Ganne, Delphine Agathon, Frank Plonski, Didier Rouy, Bettina M. Cockroft, Annie Fang, Steven Arkin
Journal: Blood (2022)
Real-World Analysis of Adverse Event Rates after Initiation of Ibrutinib Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia By Ibrutinib Discontinuation Status
Authors: Enrico De Nigris, Scott F. Huntington, Justin Puckett, Sachin Kamal-Bahl, Mohammed Z.H. Farooqui, Katherine Elizabeth Ryland, Eric Sarpong, Xiaoqin Yang, Jalpa Doshi
Journal: Blood (2022)
Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)
Authors: Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, Takashi Terauchi, Hiroaki Onaya, Masahiko Oguchi, Shinsuke Iida, Kisato Nosaka, Yasuhiro Suzuki, Yasuhiko Harada, Kana Miyazaki, Masaki Maruta, Noriko Fukuhara, Tomomi Toubai, Nobuko Kubota, Ken Ohmachi, Kazuhito Yamamoto, Takahiro Kumode, Ishikazu Mizuno, Takayuki Tabayashi, Hideki Tsujimura, Nobuyuki Takayama, Kohsuke Asagoe, Isao Yoshida, Yasushi Takamatsu, Suguru Fukuhara, Mai Takeuchi, Ukihide Tateishi, Dai Maruyama, Kunihiro Tsukasaki, Hirokazu Nagai
Journal: Blood (2022)
Clinical Features and Treatment Response in Patients with Multiple Myeloma and CD20 Expression: Real-Life Experience of the Centro-Italy Multiple Myeloma Macroregional District
Authors: Alessia Fiorini, Valentina Panichi, Maria Gabriela Chavez, Iole Cordone, Guido Montanaro, Francesca Fazio, Loredana Bassi, Valeria Tomarchio, Edoardo Sbraga, Monica Poscente, Roberta Merola, Maria Stefania De Propris, Andrea Mengarelli, Stefano Licci, Raffaella Giancola, Roberto Latagliata, Ombretta Annibali, Angela Rago, Francesca Fioritoni, Maria Teresa Petrucci, Alessandro Andriani
Journal: Blood (2022)
Trends in the Use of Hematopoietic Stem Cell Transplantation in the Management of Relapsed/Refractory Diffuse Large B Cell Lymphoma. a Retrospective Analysis of the Lymphoma Working Party of the EBMT
Authors: Anna Sureda, Ariane Boumendil, Philipp Berning, Hervé Finel, Denis Caillot, Wolf Roesler, Jürgen Finke, Igor Wolfgang Blau, Veronique Leblond, Joerg Bittenbring, Anna Tsoulkani, Ben Carpenter, Arnon Nagler, Didier Blaise, Peter Dreger, Norbert Schmitz
Journal: Blood (2022)
Mucosal-Associated Invariant T (MAIT) Cells Are Functionally Impaired in Pediatric Patients Following HCT and Their Recovery Is Associated with the Onset of GvHD
Authors: Enrico Velardi, Sara Flamini, Federica Galaverna, Emilia Boccieri, Carmen Dolores De Luca, Francesca Benini, Francesco Quagliarella, Marco Rosichini, Marialuigia Catanoso, Antonella Cardinale, Shirley Velardi, Gabriele Volpe, Angela Pitisci, Marianna Coccetti, Roberto Carta, Francesca Del Bufalo, Valentina Bertaina, Marco Becilli, Daria Pagliara, Mattia Algeri, Pietro Merli, Franco Locatelli
Journal: Blood (2022)
CD22 CAR T Cells Demonstrate Favorable Safety Profile and High Response Rates in Pediatric and Adult B-ALL: Results of a Phase 1b Study
Authors: Nikeshan Jeyakumar, Sneha Ramakrishna, Matthew J Frank, Bita Sahaf, Steven A. Feldman, David B. Miklos, Crystal L. Mackall, Kara L. Davis, Lori Muffly, Liora M. Schultz
Journal: Blood (2022)
Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host-Disease (SR-aGVHD) or Treatment-Refractory Acute Graft-Versus-Host-Disease (TR-aGVHD)
Authors: Sameem Abedin, Mehdi Hamadani, Shernan G Holtan, Gary J. Schiller, Molly Gallogly, Edmund K. Waller, Satyajit Kosuri, Sunil H Abhyankar, Sarah M. Anand, Mahasweta Gooptu, Iming Cho, Simona Reed, Shih-Yao Lin, Jesse W Hall, Paul J Martin
Journal: Blood (2022)
Characterization and Clinical Impact of the Tumor Microenvironment of Post-Transplant Large B-Cell Lymphoma
Authors: Suvi-Katri Leivonen, Terhi Friman, Samuli Vaittinen, Andreas Wind Jensen, Francesco Annibale d'Amore, Stephen Jacques Hamilton-Dutoit, Harald Holte, Klaus Beiske, Panu Kovanen, Riikka Räty, Sirpa Leppa
Journal: Blood (2022)
Pre-Clinical Evaluation of Allogeneic 'Off-the-Shelf' CAR-iNKT Cells Targeting CD19 (ALA-101)-Expressing Hematological Malignancies
Authors: Kanagaraju Ponnusamy, Janani Kanagaraju, Yingxin Wang, Bryan Lye, Hongwei Ren, Uthayamalar Armugam, Sandhya Buchanan, Michael J Baker, Mini Bharathan, Anastasios Karadimitris
Journal: Blood (2022)
Infections and Severe Hypogammaglobulinemia in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies
Authors: Guido Lancman, Kian Parsa, Cesar Rodriguez, Joshua Richter, Hearn J. Cho, Samir Parekh, Shambavi Richard, Adriana Rossi, Larysa Sanchez, Santiago Thibaud, Sundar Jagannath, Ajai Chari
Journal: Blood (2022)
Long Term Outcomes of 63 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed up to 7 Years Post-Treatment with betibeglogene autotemcel (beti-cel) Gene Therapy and Exploratory Analysis of Predictors of Successful Treatment Outcomes in Phase 3 Trials
Authors: Mark C. Walters, Janet L. Kwiatkowski, John B. Porter, Jennifer Schneiderman, Suradej Hongeng, Andreas E. Kulozik, Marina Cavazzana, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, John E.J. Rasko, Evangelia Yannaki, Shamshad Ali, Ilya Shestopalov, Maeva Fincker, Richard A. Colvin, Dustin Whitney, Franco Locatelli, Alexis A. Thompson
Journal: Blood (2022)
Real-World Treatment Patterns Among Patients with Newly-Diagnosed (ND)-Acute Myeloid Leukemia (AML) in the United States (US)
Authors: Dianne Pulte, Kelly J. Norsworthy, Laura Fernandes, Bindu Kanapuru, Catherine Lerro, Fatima Rizvi, Jonathon Vallejo, Kun Wang, Joseph Wynne, Anna Barcellos, Andrew J. Belli, Eric Hansen, Thomas Gwise, Paul Kluetz, Angelo De Claro, Ching-Kun Wang, Donna Rivera
Journal: Blood (2022)
A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) a Study of the Polish Adult Leukemia Group (AML-1/2018): Preliminary Results of the Dose Escalation Stage
Authors: Agnieszka Wierzbowska, Agnieszka Pluta, Piotr Stelmach, Marta Anna Sobas, Justyna Rybka, Tomasz Wróbel, Ewa Zarzycka, Witold Prejzner, Jan Zaucha, Andrzej Szczepaniak, Lidia Gil, Sebastian Giebel
Journal: Blood (2022)
Development of KT-253, a Highly Potent and Selective Heterobifunctional MDM2 Degrader for the Treatment of Acute Myeloid Leukemia
Authors: Michele Mayo, Yogesh Chutake, Rahul Karnik, Alice McDonald, Patricia S. Cho, Jessica Filiatrault, Dapeng Chen, Vaishali Dixit, William Proctor, Susanne Breitkopf, Frank Qi, Kan-Nian Hu, Kirti Sharma, Reggie Ewesuedo, Matt Weiss, Joseph D. Growney, Juliet Williams, Stefanie S Schalm
Journal: Blood (2022)